Truscreen Group Ltd

TRU

Company Profile

  • Business description

    Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.

  • Contact

    C/- HLB Mann Judd Limited
    57 Symonds Street
    Level 6, Equitable House
    Grafton
    Auckland1010
    NZL

    T: +64 93032243

    https://www.truscreen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    9

Stocks News & Analysis

stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
stocks

Palantir earnings: Blockbuster growth amid high expectations

We raise our fair value estimate off the back of earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,105.405.70-0.06%
CAC 407,635.0313.990.18%
DAX 4023,924.3678.290.33%
Dow JONES (US)44,193.1281.380.18%
FTSE 1009,164.3121.580.24%
HKSE24,996.7886.150.35%
NASDAQ21,169.42252.871.21%
Nikkei 22541,149.02354.160.87%
NZX 50 Index12,925.5745.410.35%
S&P 5006,345.0645.870.73%
S&P/ASX 2008,835.907.80-0.09%
SSE Composite Index3,638.394.390.12%

Market Movers